MedPath

Effect of eye ointmet lubratex in the prevetion ocular surface disorders (OSD)

Not Applicable
Conditions
Ocular Surface Disorders.
Disorders of sclera, cornea, iris and ciliary body
H19-H22
Registration Number
IRCT2017040733278N1
Lead Sponsor
Department of Technology and Research of Shahroud University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
71
Inclusion Criteria

Age over 18 years; the healthy cornea in the initial examination; admitted to the intensive care unit for at least for 5 days; consciousness score according to the Glasgow Coma Scale less than 10; lack of trauma to the face or eyes; no history of eye problems. Exclusion criteria: having chemosis; differences of scores in the preliminary examination of the eyelid position; Bell's palsy or unilateral hemiplegia; allergy to Lubratex; closed suction method; if the patient is able to blink; corneal disorder at any stage of the testing.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ocular Surface Disorders. Timepoint: Before intervention- 5 days after the intervention. Method of measurement: Assessment tools for ocular surface disorders in this study including the Schirmer's and fluorescin tests. Schirmer's test once before and once when the study is completed will be done. To perform this test graded Schirmer's paper is placed in choledosac at the junction of the middle third and outer third of the eyelid and the lid is closed. After five minutes, wet bar's height is measured in millimeters. Fluorescein test once at the beginning and once on the fifth day is done.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath